Respidin Is Contender For Alpha Therapeutic’s Proteinase Inhibitor
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Alpha Therapeutic is considering Respidin as a tradename for its alpha1 proteinase inhibitor. The name was submitted to the Patent and Trademark Office for proteinase inhibitors.